{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:15:47Z","timestamp":1791645347882,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.eprac.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:26:07Z","timestamp":1736907967000},"page":"479-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Estimated Glucose Disposal Rate Predicts the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-5410","authenticated-orcid":false,"given":"Takahiro","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Obora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-4445","authenticated-orcid":false,"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2025.01.002_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.002_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.002_bib3","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.eprac.2025.01.002_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.01.002_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14276","article-title":"Association of MASLD with the risk of extrahepatic cancers: a systematic review and meta-analysis of 18 cohort studies","author":"Zhou","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.eprac.2025.01.002_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jdi.14315","article-title":"Metabolic dysfunction-associated steatotic liver disease: a superior predictor for incident type 2 diabetes over traditional criteria \u2013 NAGALA study","author":"Sakai","year":"2024","journal-title":"J\u00a0Diabetes Investig"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.002_bib7","article-title":"Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): pathways of action of hypoglycemic agents","volume":"29","author":"Maldonado-Rojas A del","year":"2024","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/dom.13110","article-title":"Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes","volume":"20","author":"Nystr\u00f6m","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"8","key":"10.1016\/j.eprac.2025.01.002_bib10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/dc12-1693","article-title":"Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes","volume":"36","author":"Epstein","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12916-024-03582-x","article-title":"Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study","volume":"22","author":"Peng","year":"2024","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02256-5","article-title":"Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.eprac.2025.01.002_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jgh.12786","article-title":"The modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study","volume":"30","author":"Hashimoto","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1373\/clinchem.2006.078980","article-title":"\u03b3-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men","volume":"53","author":"Ryu","year":"2007","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.eprac.2025.01.002_bib16","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","article-title":"Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan","volume":"71","author":"Ogawa","year":"2024","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-022-03689-x","article-title":"Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study","volume":"22","author":"Ren","year":"2022","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.002_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(19)30425-5","article-title":"Association of insulin resistance and \u03b2-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.002_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.120.16905","article-title":"Associations of insulin resistance with systolic and diastolic blood pressure: a study from the HCHS\/SOL","volume":"78","author":"Quesada","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.eprac.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2025.01.002_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052036","article-title":"Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis","volume":"7","author":"Gast","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.eprac.2025.01.002_bib24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","article-title":"HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects","volume":"25","author":"Bonora","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib25","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","article-title":"Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study","volume":"4","author":"Lopez-Jaramillo","year":"2023","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66692-9","article-title":"Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis","volume":"14","author":"Wan","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.eprac.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1194\/jlr.M040584","article-title":"Plasma triglyceride\/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults","volume":"54","author":"Murgu\u00eda-Romero","year":"2013","journal-title":"J\u00a0Lipid Res"},{"issue":"7","key":"10.1016\/j.eprac.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","article-title":"HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects prospective data from the verona diabetes complications study","volume":"25","author":"Bonora","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.01.002_bib29","article-title":"Hs-CRP and HOMA-IR: include them in the MASLD definition, or treat them as mediators between MASLD and atherosclerotic cardiovascular disease?","author":"Wan","year":"2024","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-023-01291-9","article-title":"Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?","volume":"23","author":"Khalili","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.002_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/liv.12977","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.002_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-019-0986-7","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study","volume":"18","author":"Fan","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J\u00a0Hepatol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:57:44Z","timestamp":1762549064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1530891X25000205"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.01.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimated Glucose Disposal Rate Predicts the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}